PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique (PERiX)

September 25, 2018 updated by: Alvise Martini, Azienda Ospedaliera Universitaria Integrata Verona

PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique: Outcome Influence on Patient Underwent Pancreatic Surgery

The use of epidural catheters for postoperative analgesia in pancreatic surgery is recommended by the guidelines of the ERAS society. Some studies claim it may expose to hemodynamic alterations that may compromise outcome and increase postoperative complications, attributable to a malfunction of the catheter itself, often linked to a bad positioning, since this is usually positioned with LOS technique. Our hypothesis is that a positioning made using the radiographic guide the day before the intervention can significantly reduce the number of catheter's dysfunctions.

Study Overview

Detailed Description

About 30% of epidural catheters are reported to have hypo or hyper functioning behaviour. This has and impact on postoperative pain control and can affect also surgical and global outcome since it is known that a malfunctional catheter carries an increased complication's rate.

Our hypothesis is that rx-guided positioning can reduce the incidence of catheter malfunction afrom 30 to 15 %.

Study Type

Interventional

Enrollment (Anticipated)

154

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Veneto
      • Verona, Veneto, Italy, 37126
        • Recruiting
        • Azienda ospedaliero-universitaria integrata Verona
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • scheduled for open pancreatic surgery
  • ASA < = 3

Exclusion Criteria:

  • scoliosis
  • coagulation abnormalities
  • antiplatelet drugs (except ASA)
  • history of back surgery
  • anticipated need of ICU stay

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: LOS group
Patients randomized to recieve epidural catheter placement with LOS technique, without any Rx control
placement of epidural catheters with LOS technique
Experimental: X-ray group
Patients randomized for X-ray placement of epidural catheter
placement of epidural catheters with x-ray guide

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of catheters malfunctions in LOS and X-ray group
Time Frame: every day until 7th postoperative day

malfunctional catheters are defined as following:

  • symptomatic hypotension due to epidural infusion
  • NRS > 6 in the first postoperative day and NRS > 4 in subsequent postoperative day
  • overt malpositioning:
  • rx evidence of catheter's tip under T10 during routine rx or TC
  • NRS > 6 (due to pain at T7-10 dermatomers) with 5 cc/h catheter infusion and response to lidocaine 1% 6ml bolus (low tip)
  • NRS > 6 (due to pain at T7-10 dermatomers) with 5 cc/h catheter infusion and NO response to lidocaine 1% 6ml bolus ( not in epidural space or very low tip)
  • evidence of catheter accidental removal

Numerical Rating Scale (NRS) is used to assess pain. Patients self-report actual pain on 0 to 10 scale where 0 is no pain and 10 is the worst immaginable pain.

every day until 7th postoperative day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evaluate daily pain differences between groups: NRS (Numeric rating scale)
Time Frame: every day until 7th postoperative day

Parameter used

-higher postoperative daily numeric rating scale (NRS) until catheter removal

Numerical Rating Scale (NRS) is used to assess pain. Patients self-report actual pain on 0 to 10 scale where 0 is no pain and 10 is the worst immaginable pain.

every day until 7th postoperative day
Monitoring postoperative surgical complications between groups
Time Frame: at 30th postoperative day

Complications are considered as:

  • bleedings
  • infections
  • pancreatic fistulas (degree)
  • biliary fistulas
  • abdominal collections
  • ICU admission
  • needs of new surgery (for any reasons)
  • pneumonia
  • delayed gastric emptying
at 30th postoperative day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alvise Martini, MD, AOUI Verona

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Anticipated)

September 30, 2018

Study Completion (Anticipated)

September 30, 2019

Study Registration Dates

First Submitted

June 27, 2018

First Submitted That Met QC Criteria

September 25, 2018

First Posted (Actual)

September 26, 2018

Study Record Updates

Last Update Posted (Actual)

September 26, 2018

Last Update Submitted That Met QC Criteria

September 25, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Clinical Trials on LOS

3
Subscribe